Andere Kunden interessierten sich auch für
![Magnetic Nanomaterials for Hyperthermia-Based Therapy, Imaging, and Drug Delivery]( "Magnetic Nanomaterials for Hyperthermia-Based Therapy, Imaging, and Drug Delivery")
Magnetic Nanomaterials for Hyperthermia-Based Therapy, Imaging, and Drug Delivery99,99 €![Cell Therapy, Stem Cells and Brain Repair]( "Cell Therapy, Stem Cells and Brain Repair")
Cell Therapy, Stem Cells and Brain Repair154,99 €![Treatments for Squamous Cell Cancer]( "Treatments for Squamous Cell Cancer")
Treatments for Squamous Cell Cancer63,99 €![Non-small Cell Lung Cancer]( "Non-small Cell Lung Cancer")
Non-small Cell Lung Cancer81,99 €![Small Cell Lung Cancer]( "Small Cell Lung Cancer")
Small Cell Lung Cancer57,99 €![Cardiovascular and Pulmonary Physical Therapy, Third Edition]( "Cardiovascular and Pulmonary Physical Therapy, Third Edition")
Cardiovascular and Pulmonary Physical Therapy, Third Edition116,99 €![Degenerative Disc Disease Explained. Including Treatment, Surgery, Symptoms, Exercises, Causes, Physical Therapy, Neck, Back, Pain, and Much More! Fac]( "Degenerative Disc Disease Explained. Including Treatment, Surgery, Symptoms, Exercises, Causes, Physical Therapy, Neck, Back, Pain, and Much More! Fac")
Degenerative Disc Disease Explained. Including Treatment, Surgery, Symptoms, Exercises, Causes, Physical Therapy, Neck, Back, Pain, and Much More! Fac14,99 €
This Special Issue in Cancers is focused on cell therapy, bispecific antibodies, and other immunotherapies against cancer. It includes reports on cell therapies such as CAR-NK cell therapies, and bispecific antibodies against multiple myeloma and B cell lymphoma. Immunotherapies against solid tumors include TGF-beta-PDL-1 fusion protein and EpCAM-CD3 bispecific antibody generated with mRNA-lipid nanoparticles (LNP) against colorectal tumors. The clinical studies ongoing with bi- and tri-specific T cell engager antibodies against solid tumors and advantages versus cell therapies are discussed. This Special Issue highlights novel approaches to cell therapies, bispecific antibodies, vaccines, and immunotherapies that will be interesting for cancer cell researchers, biologists, and oncologists.